Who is sponsoring NCT04383379?

NCT04383379 is sponsored by Nanjing Medical University.

What drugs are being tested in NCT04383379?

Interventions in NCT04383379: Experimental: Intervention group.

What condition does NCT04383379 study?

NCT04383379 studies Quality Improvement, Breast-feeding, Premature Infant.

Is NCT04383379 still recruiting?

NCT04383379 is currently status unknown. Last updated 1 November 2021.

Last reviewed 2021-11-01 · How we verify

NCT04383379

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

To Improve the Rate of Mother's Own Milk Feeding of Premature Infants in NICU

Status unknown NA Last updated 1 November 2021

What this trial tests

NA trial testing Experimental: Intervention group in Quality Improvement in 1,500 participants. Status unknown.

Timeline

15 May 2020

Primary endpoint
30 April 2022

30 April 2022

Quick facts

Lead sponsor	Nanjing Medical University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	1,500
Start date	15 May 2020
Primary completion	30 April 2022
Estimated completion	30 April 2022
Sites	1 location across China

Drugs / interventions tested

Experimental: Intervention group

Conditions studied

Quality Improvement — all drugs for Quality Improvement →
Breast-feeding — all drugs for Breast-feeding →
Premature Infant — all drugs for Premature Infant →

Sponsor

Nanjing Medical University

Who can join

Under 120 Days, any sex, with Quality Improvement or Breast-feeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Thirteen hospitals in China will participate in the study, which objectives of this study is to improve the rate of mother's own milk feeding of premature infants in neonatal intensive care unit(NICU), evaluate the effectiveness of improving the quality of breastfeeding in clinical use ,form standardized process and improve clinical medical quality of premature infants.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Using a WeChat mini-program-based lactation consultant intervention to increase the consumption of mother's own milk by preterm infants in the neonatal intensive care unit: a study protocol for a cluster randomized controlled trial.
Huo J, Wu X, Gu C, Yu Z, et al · · 2021 · cited 6× · PMID 34819117 · DOI 10.1186/s13063-021-05731-6

Verify or expand the search:

Other trials of Experimental: Intervention group

Trials testing the same drug.

NCT06801691 — The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe · NA · recruiting
NCT04958941 — CUIDA-TE, an APP for the Emotional Management · NA · completed

Other recruiting trials for Quality Improvement

Currently open trials in the same condition.

NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
NCT06701929 — The Impact of Fasting Duration on Quality of Recovery After Cesarean Section · recruiting
NCT06873243 — Developing a Learning Health System for Primary Care in Thailand · NA · active not recruiting
NCT06733805 — Impact Evaluation of the Therapeutic Initiative's Type 2 Diabetes in Older Adults Portrait and Therapeutics Letter · NA · active not recruiting
NCT06738004 — National Emergency Bariatric Surgery Audit · recruiting

Other Nanjing Medical University trials

Trials by the same sponsor.

NCT07382375 — AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection · NA · not yet recruiting
NCT07494474 — Risk Assessment of Pancreatic Islet Autoimmunity in Patients With AITD · not yet recruiting
NCT07482774 — Tumor Microenvironment Changes After Neoadjuvant Chemo-Immunotherapy in Esophageal Squamous Cell Carcinoma · not yet recruiting
NCT07348328 — Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery · NA · not yet recruiting
NCT07258394 — Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04383379 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nanjing Medical University
Last refreshed: 1 November 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04383379.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing